CD36 and pulmonary fibrosis: Specifically, Parks and colleagues demonstrated that CD36-null mice exhibited an attenuated capacity to clear apoptotic alveolar cells after bleomycin injury and that this decreased uptake of apoptotic bodies attenuated the severity of lung fibrosis [6].